☆ 4.6 Meeting Abstract

LIPOPROTEIN(A), PCSK9 INHIBITION AND CARDIOVASCULAR RISK: INSIGHTS FROM THE FOURIER TRIAL

ATHEROSCLEROSIS (2018)

Get Full Text
Add to Collection

Journal

ATHEROSCLEROSIS
Volume 275, Issue -, Pages E9-E10

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2018.06.912

Keywords

-

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.